• 00Days
  • 00Hrs
  • 00Mins
  • 00Secs

Chair: Shamira PERERA (Singapore)

Date & Time: Friday, 24 July 2026, 1245 – 1345 hrs         Venue: Level 4, Hall 406CX

This symposium will explore the evolving role of first-line glaucoma therapy through eight years of real-world experience with Eybelis in Asia. Participants will receive updates from the 4th APGG on Eybelis positioning within current treatment algorithms, together with insights into long-term clinical outcomes. An expert panel will share practical experiences and discuss how Eybelis may be integrated into routine clinical practice for glaucoma care.

Time Presentation Topic Speaker
1245 – 1255 Updates from the 4th APGG: Positioning Eybelis within the treatment algorithm Shamira PERERA
Singapore
1255 – 1310 Updates on Real-world Evidence: Long-term Clinical Outcomes with Eybelis JIN Wook Jeoung
South Korea
1310 – 1340 Key Takeaways from the Asia Expert Panel: Insights from Eight Years of Real-world Eybelis Experience Shamira PERERA (Singapore)
JIN Wook Jeoung (South Korea)
Makoto AIHARA (Japan)
Manchima MAKORNWATTANA (Thailand)
1340 – 1345 Conclusion Shamira PERERA
Singapore

Abstract submission deadline extended

Important dates
Good News! Abstract Submission Now Open Until 21 February 2026